SCHEMBL5378674

SCHEMBL5378674

O=C(O)c1cc(S(=O)(=O)Nc2ccc(SCc3ccc(C(F)(F)F)cc3)cc2)ccc1Cl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
AVPR2 P30518 1/20 0.48
GPR27 Q9NS67 1/20 0.48
MIF P14174 1/20 0.46
LMNA P02545 1/20 0.46
TP53 P04637 1/20 0.45
MCL1 Q07820 2/20 0.44
BCL2A1 Q16548 1/20 0.44
SERPINE1 P05121 1/20 0.44
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC10 Q969S8 1/20 0.44
HDAC11 Q96DB2 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
HDAC9 Q9UKV0 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5371856 0.88 POLB (0.53) MEN1KMT2AMCL1BCL2A1SERPINE1
SCHEMBL5371913 0.87 ALDH1A1 (0.47) MEN1KMT2AAVPR2GPR27MCL1
SCHEMBL5369923 0.82 AR (0.66) MEN1KMT2AAVPR2GPR27MIF
SCHEMBL5382460 0.82 MEN1 (0.52) MEN1KMT2AMCL1BCL2A1SERPINE1
SCHEMBL5368417 0.81 ALOX15 (0.48) MEN1KMT2AAVPR2GPR27HDAC3
SCHEMBL5373144 0.80 POLB (0.53) MCL1BCL2A1SERPINE1HDAC3HDAC4
SCHEMBL5376719 0.80 KMT2A (0.57) MEN1KMT2AMIFLMNATP53
SCHEMBL5376747 0.79 POLB (0.54) MEN1KMT2ALMNAMCL1BCL2A1
SCHEMBL5388054 0.79 POLB (0.56) MEN1KMT2ALMNAMCL1BCL2A1
SCHEMBL5369948 0.78 POLB (0.53) MEN1KMT2ALMNAMCL1BCL2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD MEN1 4855/4885KMT2A 3530/4885AVPR2 4112/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD MEN1 4861/4885KMT2A 3601/4885AVPR2 3958/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.